Vitamin D Deficiency Clinical Trial
Official title:
The Changes of Body Composition, Glucolipid Metabolism and Bone Metabolism in Obese Children and Adolescents After Weight Loss Camp
Vitamin D plays a significant role in calcium and phosphorus homeostasis for maintaining
structural integrity and function of musculoskeletal system. Furthermore, recent studies have
revealed that vitamin D can decrease the risk of many conditions other than skeletal disease,
including autoimmune diseases, cancers, obesity and obesity-related diseases, such as type 2
diabetes and cardiovascular disease. Vitamin D may influence calcium absorption to affect
obesity indirectly, regulate adipocyte differentiation and relieve the development of
metabolic syndrome by mediating levels of inflammatory factors.
Another indicator of bone metabolism—osteocalcin may also be involved in energy metabolism
and glucose metabolism, and undercarboxylated osteocalcin (ucOC) is the form which has
physiological activity. ucOC may recombine with the receptors on the surface of pancreas β
cells, adipocytes, hepatocytes and intestinal endocrine cell to regulate insulin secretion
and insulin sensitivity.
Currently, the prevalence of vitamin D deficiency is a global problem in all age groups
currently, even in countries with sun exposure all year around. The obesity group tend to
have a higher incidence of vitamin D deficiency.Moreover, the obesity group tend to have a
higher incidence of vitamin D deficiency and a lower level of serum osteocalcin.
This study observed the changes of body composition and glucolipid metabolism and bone
metabolism during weight loss, and investigated the correlations among them.
Obese children have a higher incidence of vitamin D deficiency (VDD), which resulted from
unhealthy life style such as less time outdoors, more sedentary time, imbalance of dietary
intake. Adipose tissue is the storage position of vitamin D, and the storage formation
include 25-OHD2 and 25-OHD3. Theoretically, the reserves of vitamin D in adipose tissue of
obese children might release to the circulation after weight loss. For further, it is
necessary to clarify the relationship between the improvement of metabolic risk with vitamin
D status after weight loss.
Osteocalcin is produced and secreted by osteoblast specifically. Recent studies have shown
that it regulated glucose metabolism and energy metabolism. Obese group may have a lower
level of serum osteocalcin. Both 25-OHD and osteocalcin have association with energy
metabolism. This study will provide evidence to realize the relationship between bone
metabolism and obesity.
In our study, all subjects were recruited from the obese children and adolescents aged 9~17
years who participated in six-week weight loss camp in July ~ August, 2014. Body mass index
(BMI) was calculated as weight (kg) divided by height squared (m2). Obesity was defined as
having a BMI greater than or equal to the 95th percentile for age and sex according to WHO
standard. Exclusion criteria included: 1) obesity caused by endocrine or heredity diseases
(eg, hypothyroidism, Prader-Willi syndrome, single-gene defects); 2) any disease influencing
vitamin D metabolism (eg, such as metabolic bone diseases, rickets, nephritic syndrome and
hepatic failure); 3) any supplementation use or any medication affecting vitamin D metabolism
use.
All subjects underwent a closed-off weight loss program for six weeks. The intervention
methods included aerobic exercise and appropriate caloric control. The dietary was designed
on the basis of ensuring the daily energy physiological requirement, and basal metabolic rate
(BMR) was calculated to formulate diet project according to Harris-Benedict formula. The diet
was composed of 20% protein, 30% fat and 50% carbohydrates. During the camp, all subjects had
never taken any kinds of nutritional supplements.
Before intervention, all subjects received exercise load test to ensure safe and effective
physical exercise. In the exercise, heart rate was monitored to ensure the small-medial load
aerobic exercise. The exercise programs included ball games, such as badminton, table tennis,
and basketball, and also included jogging, brisk walking, swimming and cycle ergometer. All
kinds of sports were conducted indoor, twice per day, 6 days per week, and lasted for 2 hours
every time. The weight loss camp was staffed by professional sports coaches and medical
workers. Exercise intensity was estimated by a formula: exercise intensity (target heart
rate) =resting heart rate + heart rate reserve (maximum heart rate-resting heart rate) ×
(20%~40%).
Before and after intervention, fasting blood samples were collected and sent to Shanghai
Adicon Central Lab Test Menu immediately stored in 4°C ice packs. The indicators of
glucolipid metabolism and bone metabolism were tested. Total cholesterol (TC) with
cholesterol oxidase, triglyceride (TG) with enzyme method (GPO-POD), high density lipoprotein
(HDL) and low density lipoprotein (LDL) with homogeneous methods, fasting blood glucose (FBG)
with hexokinase (HK) method, fasting insulin (FINS) with chemiluminescence method. Among the
indicators of bone metabolism, osteocalcin, parathyroid hormone (PTH) and 25-OHD were assayed
by electrochemiluminescence immunoassay, while bone specific alkaline phosphatase (BALP),
total propeptide of type I procollagen (T-PINP) and β-isomerized form carboxy-terminal
telopeptide of type I collagen (β-CTX) were determined by immunoenzymatic methods.
After blood samples were collected, anthropometric parameters were measured, including height
(Seca 264, Germany), weight (Biospace 370, South Korea), triceps skinfold thickness (TST) and
subscapular skinfold thickness (SST) (skinfold caliper 689900). For error reduction, every
anthropometric measurement was conducted by the same trained personnels before and after
weight-loss.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04244474 -
Effect of Vitamin D Supplementation on Improvement of Pneumonic Children
|
Phase 1/Phase 2 | |
Recruiting |
NCT05459298 -
ViDES Trial (Vitamin D Extra Supplementation)
|
N/A | |
Suspended |
NCT03652987 -
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
|
||
Completed |
NCT04476511 -
The Efficacy and the Safety of Vitamin D3 30,000 IU for Loading Dose Schedules
|
Phase 3 | |
Completed |
NCT03920150 -
Vitamin D 24'000 IU for Oral Intermittent Supplementation
|
Phase 3 | |
Completed |
NCT03264625 -
The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis
|
Phase 2 | |
Completed |
NCT04183257 -
Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
|
Phase 4 | |
Recruiting |
NCT05084248 -
Vitamin D Deficiency in Adults Following a Major Burn Injury
|
Phase 4 | |
Completed |
NCT05506696 -
Vitamin D Supplementation Study
|
N/A | |
Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
Completed |
NCT03234218 -
Vitamin D Levels in Liver Transplantation Recipients Prospective Observational Study
|
||
Completed |
NCT02714361 -
A Study to Investigate the Effect of Vitamin D3 Supplementation on Iron Status in Iron Deficient Women
|
N/A | |
Completed |
NCT03203382 -
Corneal Nerve Structure in Sjogren's
|
||
Completed |
NCT02906319 -
Vitamin D and HbA1c Levels in Diabetic Patients With CKD
|
N/A | |
Completed |
NCT02118129 -
Vitamin D Among Young Adults: an Intervention Study Using a Mobile 'App'.
|
N/A | |
Completed |
NCT02187146 -
The Effects of Serum Vitamin D and IVF Outcome
|
N/A | |
Not yet recruiting |
NCT01419821 -
Vitamin D and Its Affect on Growth Rates and Bone Mineral Density Until Age 5
|
N/A | |
Completed |
NCT02275650 -
The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter
|
N/A | |
Completed |
NCT01741181 -
Vitamin D Supplementation in Patients With Diabetes Mellitus Type 2
|
Phase 4 | |
Completed |
NCT01688102 -
The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile
|
N/A |